OXiGENE is led by a talented team of business, medical, and drug development / discovery professionals with extensive biopharmaceutical industry experience.

Peter J. Langecker, M.D., Ph.D
Interim Chief Executive Officer

Dai Chaplin, Ph.D.
Head of Research and Development & Chief Scientific Officer

James B. Murphy
Vice President and Chief Financial Officer